Add like
Add dislike
Add to saved papers

The Signal Intensity Ratio of Pancreas to Spleen in Magnetic Resonance Imaging Can Predict Nonalcoholic Fatty Liver Disease After Pancreaticoduodenectomy.

Pancreas 2024 Februrary 15
OBJECTIVES: Signal intensity ratio of pancreas to spleen (SI ratiop/s) on fat-suppressed T1-weighted images of magnetic resonance imaging has been associated with pancreatic exocrine function. We here investigated the predictive value of the SI ratiop/s for the development of nonalcoholic fatty liver disease (NAFLD) after pancreaticoduodenectomy (PD).

MATERIALS AND METHODS: This study comprised 208 patients who underwent PD. NAFLD was defined as a liver-to-spleen attenuation ratio of <0.9 calculated by a computed tomography 1 year after surgery. SI ratiop/s was calculated by dividing the average pancreas SI by the spleen SI. We retrospectively investigated the association of clinical variables including the SI ratiop/s and NAFLD by univariate and multivariate analyses.

RESULTS: NAFLD after 1 year was developed in 27 patients (13%). In multivariate analysis, the SI ratiop/s < 1 (P < 0.001) was an independent predictor of incidence of NAFLD. The SI ratiop/s < 1 was associated with low amylase level of the pancreatic juice (P < 0.001) and progressed pancreatic fibrosis (P = 0.017). According to the receiver operating characteristics curve, the SI ratiop/s had better prognostic ability of NAFLD than the remnant pancreas volume.

CONCLUSIONS: The SI ratiop/s is useful to predict NAFLD development after PD. Moreover, the SI ratiop/s can be a surrogate marker, which represents exocrine function of the pancreas.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app